Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[S,S]-Reboxetine Extension in Fibromyalgia
NCT00754221Phase 3Terminated
- Sponsor
- Pfizer
- Start
- May 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of esreboxetine in fibromyalgia (FM), sponsored by Pfizer. Started May 2008; status: terminated.
02
Drugs
esreboxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00754221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754221.